Combined modality treatment of stage III and inflammatory breast cancer. M.D. Anderson Cancer Center experience.

Surgical oncology clinics of North America

Volumn 4, Issue 4, 1995, Pages 715-734

  Buzdar, A U ^a   Singletary, S E ^a   Booser, D J ^a   Frye, D K ^a   Wasaff, B ^a   Hortobagyi, G N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADENOCARCINOMA; ARTICLE; BREAST TUMOR; CANCER STAGING; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MULTIMODALITY CANCER THERAPY; PATHOLOGY;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; NEOPLASM STAGING;

MLCS; MLOWN;

EID: 0029383127     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1055-3207(18)30426-5     Document Type: Article

References (0)